CAMP4 Therapeutics Latest Filings
Event
01/07/2025
Form 8-K - Current report
Item 8.01: Other Events
Item 7.01: Regulation FD Disclosure
Interim
11/21/2024
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Report Period: Q3' FY2024
Financial Results:
: revenue $0.00;
: EPS $-24.19
Event
11/21/2024
Form 8-K - Current report
Item 2.02: Results of Operations
Ownership
10/22/2024
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Ownership
10/22/2024
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Ownership
10/22/2024
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
10/22/2024
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Ownership
10/22/2024
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Ownership
10/22/2024
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Ownership
10/22/2024
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Show More Filings
